Lía Randall-Carlevaro
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Lía Randall-Carlevaro has a total of 19 co-authors. Here are the top co-authors by number of shared publications:
- Guzmán Alvarez
Laboratorio de Moléculas Bioactivas Departamento de Ciencias Biológicas CENUR Litoral Norte Universidad de la República Paysandú Uruguay
2 shared publications - Ana Clara Segovia
Laboratorio de Moléculas Bioactivas, Departamento de Ciencias Biológicas, CENUR Litoral Norte, Universidad de La República, Uruguay
1 shared publication - Augusto Ernesto Bivona
Cátedra de Inmunología, Facultad de Farmacia y Bioquímica, Universidad de Buenos Aires, Junín 956 4° floor, Buenos Aires 1113, Argentina
1 shared publication - Cesar Atilio Nazareno Catalan
Universidad Nacional de Tucumán
1 shared publication - Christophe Guillon
Retroviruses and Structural Biochemistry Team, Molecular Microbiology and Structural Biochemistry, MMSB, CNRS UMR 5086, Université de Lyon , 69007 Lyon
1 shared publication - Emilio Luis Malchiodi
Cátedra de Inmunología, Facultad de Farmacia y Bioquímica, Universidad de Buenos Aires, Buenos Aires 1113, Argentina
1 shared publication
Latest Publications
- 14 March 2025
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 763, 151572
Integrating different approaches for the identification of new disruptors of HIV-1 capsid multimerization
- 14 March 2025
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 763, 151572
Integrating different approaches for the identification of new disruptors of HIV-1 capsid multimerization
- Open Access
- 15 February 2023
- Published by MDPI AG in Pharmaceutics
- Vol. 15 (2) , 647
Anti-Trypanosoma cruzi Properties of Sesquiterpene Lactones Isolated from Stevia spp.: In Vitro and In Silico Studies
Stevia species (Asteraceae) have been a rich source of terpenoid compounds, mainly sesquiterpene lactones, several of which show antiprotozoal activity. In the search for new trypanocidal compounds, S. satureiifolia var. satureiifolia and S. alpina were studied. Two sesquiterpene lactones, santhemoidin C and 2-oxo-8-deoxyligustrin, respectively, were isolated. These compounds were assessed in vitro against Trypanosoma cruzi stages, showing IC50 values of 11.80 and 4.98 on epimastigotes, 56.08 and 26.19 on trypomastigotes and 4.88 and 20.20 µM on amastigotes, respectively. Cytotoxicity was evaluated on Vero cells by the MTT assay. The effect of the compounds on trypanothyone reductase (TcTR), Trans-sialidase (TcTS) and the prolyl oligopeptidase of 80 kDa (Tc80) as potential molecular targets of T. cruzi was investigated. Santhemoidin C inhibited oligopeptidase activity when tested against recombinant Tc80 using a fluorometric assay, reaching an IC50 of 34.9 µM. Molecular docking was performed to study the interaction between santhemoidin C and the Tc80 protein, reaching high docking energy levels. Plasma membrane shedding and cytoplasmic vacuoles, resembling autophagosomes, were detected by transmission microscopy in parasites treated with santhemoidin C. Based on these results, santhemoidin C represents a promising candidate for further studies in the search for new molecules for the development of trypanocidal drugs.
- 15 February 2023
- Published by MDPI AG in Pharmaceutics
- Vol. 15 (2) , 647
Open AccessAnti-Trypanosoma cruzi Properties of Sesquiterpene Lactones Isolated from Stevia spp.: In Vitro and In Silico Studies
Stevia species (Asteraceae) have been a rich source of terpenoid compounds, mainly sesquiterpene lactones, several of which show antiprotozoal activity. In the search for new trypanocidal compounds, S. satureiifolia var. satureiifolia and S. alpina were studied. Two sesquiterpene lactones, santhemoidin C and 2-oxo-8-deoxyligustrin, respectively, were isolated. These compounds were assessed in vitro against Trypanosoma cruzi stages, showing IC50 values of 11.80 and 4.98 on epimastigotes, 56.08 and 26.19 on trypomastigotes and 4.88 and 20.20 µM on amastigotes, respectively. Cytotoxicity was evaluated on Vero cells by the MTT assay. The effect of the compounds on trypanothyone reductase (TcTR), Trans-sialidase (TcTS) and the prolyl oligopeptidase of 80 kDa (Tc80) as potential molecular targets of T. cruzi was investigated. Santhemoidin C inhibited oligopeptidase activity when tested against recombinant Tc80 using a fluorometric assay, reaching an IC50 of 34.9 µM. Molecular docking was performed to study the interaction between santhemoidin C and the Tc80 protein, reaching high docking energy levels. Plasma membrane shedding and cytoplasmic vacuoles, resembling autophagosomes, were detected by transmission microscopy in parasites treated with santhemoidin C. Based on these results, santhemoidin C represents a promising candidate for further studies in the search for new molecules for the development of trypanocidal drugs.